Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Chongqing Zhifei Biological Products

CanSino’s new crown vaccine is recognized by the WHO. Why do brokerages still give the industry a cautious recommendation rating? New Coronary Pneumonia_Sina Finance_Sina.com

  • Post date May 20, 2022 — 17:54 Post Lock Login to View

Read More

CanSino’s new crown vaccine is recognized by the WHO. Why do brokerages still give the industry a cautious recommendation rating? CFi.CN

  • Post date May 20, 2022 — 17:35 Post Lock Login to View

Read More

Leveraged funds lighten their positions on ChiNext stocks for four consecutive days_ Securities Times Network

  • Post date May 17, 2022 — 10:35 Post Lock Login to View

Read More

Caitong Boom Industry Mixed Net Value Up 3.34% Earnings_Sina Finance_Sina Net

  • Post date May 17, 2022 — 07:08 Post Lock Login to View

Read More

The financing balance of GEM companies decreased by 705 million yuan during the three consecutive declines_Oriental Fortune Net

  • Post date May 16, 2022 — 11:24 Post Lock Login to View

Read More

Tracking of listed companies in Sichuan and Chongqing_ Oriental Fortune Net

  • Post date May 13, 2022 — 21:03 Post Lock Login to View

Read More

Heavily placed bets on Maotai are making a lot of money, private placement stocks have reached 1,432, and the list of TOP20 stocks to increase their holdings has been released! -Funds Financial Sector

  • Post date May 13, 2022 — 19:04 Post Lock Login to View

Read More

Morgan Stanley Health Industry Mixed C Net Worth Up 3.81%

  • Post date May 12, 2022 — 07:46 Post Lock Login to View

Read More

China Universal CSI Precision Medicine Index (LOF) A Net Value Up 3.43% China Universal

  • Post date May 12, 2022 — 07:40 Post Lock Login to View

Read More

Yinhua CSI Innovative Drug Industry ETF Net Value Up 3.08%

  • Post date May 12, 2022 — 07:30 Post Lock Login to View

Read More

E Fund CSI Innovative Drug Industry ETF Net Value Up 3.06% E Fund

  • Post date May 12, 2022 — 07:29 Post Lock Login to View

Read More

GF China Securities Innovative Drug Industry ETF Net Value Up 3.12%

  • Post date May 12, 2022 — 07:27 Post Lock Login to View

Read More

Cathay CSI Shanghai-Hong Kong-Shenzhen Innovative Drug Industry ETF Net Value Up 3.23% Cathay Pacific

  • Post date May 12, 2022 — 07:26 Post Lock Login to View

Read More

ICBC Credit Suisse CSI Innovative Drug Industry ETF Net Value Up 3.07% ICBC Credit Suisse

  • Post date May 12, 2022 — 07:24 Post Lock Login to View

Read More

The latest private equity fund news: A-shares are the most uncomfortable, tens of billions of private equity Gao Yi Assets, Ningquan Assets Yang Dong are actively bottom-hunting, some people "earn treasures" and some "buy thunder" Yahui.com

  • Post date May 11, 2022 — 22:15 Post Lock Login to View

Read More

Zhifei Bio: The pipeline under development has gradually entered the harvest period

  • Post date May 11, 2022 — 20:46 Post Lock Login to View

Read More

Zhifei Bio: The company has now developed into a high-tech biopharmaceutical enterprise integrating R&D, production, sales and import and export

  • Post date May 11, 2022 — 20:45 Post Lock Login to View

Read More

Zhifei Bio: The company has a total of 11 products on the market

  • Post date May 11, 2022 — 20:44 Post Lock Login to View

Read More

Zhifei Bio: The batch release information of the product will continue to be published in the China National Institute for Food and Drug Control

  • Post date May 11, 2022 — 20:14 Post Lock Login to View

Read More

Equity private equity funds are "cold in spring": the median yield in the first four months is -17%, and many privately held stocks plunged by more than 30% in April.

  • Post date May 11, 2022 — 17:18 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.